Hope that there is a buyout once they go current and the price offered is a genuine indication of potential.
Running trials is not easy, especially as RGBP does not have the means or infrastructure to do that. I would rather have another company that has the capability and past experience to do that. Building that capability is going to take time, money and effort. Just my opinion.
Remains to be seen how much will be offered for all of the patents. Is it going to be sub dollar or higher than that? Would partly depend on Koots negotiating skills and business background/experience.
We will cross that bridge when we get there. For now pink current is all that I care about and it seems we will get there well before the SEC deadline.